Imagion Biosystems Ltd.(AU:IBX)
A$0.010.00 (0.00%)
AU:IBX
Imagion Biosystems Ltd. financials statements
A$0.01
At close:0.00 (0.00%)
Want to see AU:IBX full AI Analyst Report?
Imagion Biosystems Ltd. (IBX) Ratios
18 Followers
Imagion Biosystems Ltd. Ratios
AU:IBX's free cash flow for Q2 2026 was AU$-1.79M. For the 2026 fiscal year, AU:IBX's free cash flow was increased by AU$0.00 and operating cash flow was AU$-1.79M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.48 | 0.55 | 0.12 | 2.88 | 17.74 |
| Quick Ratio | 0.48 | 0.55 | 0.12 | 2.70 | 17.52 |
| Cash Ratio | 0.44 | 0.53 | 0.04 | 2.57 | 17.26 |
| Solvency Ratio | -1.02 | -0.40 | -1.35 | -1.64 | -6.94 |
| Operating Cash Flow Ratio | -0.96 | -0.25 | -1.62 | -5.02 | -6.53 |
| Short-Term Operating Cash Flow Coverage | -1.60 | -0.45 | -4.89 | -8.36 | -334.75 |
| Net Current Asset Value | AU$ -2.17M | AU$ -2.30M | AU$ -7.77M | AU$ -309.58K | AU$ 12.96M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.25 | 1.02 | 1.32 | 0.46 | 0.00 |
| Debt-to-Equity Ratio | -1.19 | -1.25 | -1.59 | 0.98 | 0.00 |
| Debt-to-Capital Ratio | 6.37 | 5.05 | 2.68 | 0.50 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.25 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.95 | -1.23 | -1.21 | 2.13 | 1.06 |
| Debt Service Coverage Ratio | -1.05 | -0.07 | -2.39 | -7.01 | -130.82 |
| Interest Coverage Ratio | -4.23 | -0.66 | -13.86 | -69.63 | -1063.24 |
| Debt to Market Cap | 0.36 | 2.70 | 0.23 | 0.04 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.09 | 0.24 | 0.17 | 0.00 |
| Net Debt to EBITDA | -0.20 | -0.25 | -0.56 | -0.01 | 2.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 84.95% | -25.84% | -663.76% | -1061.20% |
| EBIT Margin | 0.00% | -28.05% | -1060.84% | -2562.97% | -2585.36% |
| EBITDA Margin | 0.00% | -26.27% | -951.58% | -2328.90% | -2411.68% |
| Operating Profit Margin | 0.00% | -28.39% | -1443.74% | -2564.09% | -3570.53% |
| Pretax Profit Margin | 0.00% | -93.96% | -1478.20% | -2071.53% | -2587.21% |
| Net Profit Margin | 0.00% | -77.56% | -1151.86% | -2071.95% | -2587.21% |
| Continuous Operations Profit Margin | 0.00% | -77.56% | -1151.86% | -2071.53% | -2587.21% |
| Net Income Per EBT | 99.07% | 82.54% | 77.92% | 100.02% | 100.00% |
| EBT Per EBIT | 121.35% | 331.01% | 102.39% | 80.79% | 72.46% |
| Return on Assets (ROA) | -210.82% | -73.72% | -271.98% | -98.33% | -42.68% |
| Return on Equity (ROE) | 199.33% | 90.54% | 329.30% | -209.71% | -45.28% |
| Return on Capital Employed (ROCE) | 165.82% | 33.14% | 2886.49% | -147.27% | -62.33% |
| Return on Invested Capital (ROIC) | -882.39% | -110.65% | -540.51% | -87.59% | -35.23% |
| Return on Tangible Assets | -210.82% | -73.72% | -271.98% | -98.33% | -42.68% |
| Earnings Yield | -62.12% | -199.95% | -115.27% | -36.45% | -7.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 3008.05 | 14.70 | 5.12 | 7.43 |
| Payables Turnover | 0.01 | 0.19 | 3.30 | 11.12 | 6.31 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 11.47 | 15.49 |
| Fixed Asset Turnover | 0.00 | 145.84 | 0.27 | 0.09 | 0.67 |
| Asset Turnover | 0.00 | 0.95 | 0.24 | 0.05 | 0.02 |
| Working Capital Turnover Ratio | 0.00 | -0.78 | -1.70 | 0.06 | 0.02 |
| Cash Conversion Cycle | -49528.57 | -1887.74 | -85.71 | 70.28 | 14.88 |
| Days of Sales Outstanding | 0.00 | 0.12 | 24.84 | 71.29 | 49.13 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 31.81 | 23.56 |
| Days of Payables Outstanding | 49528.57 | 1887.86 | 110.54 | 32.81 | 57.81 |
| Operating Cycle | 0.00 | 0.12 | 24.84 | 103.10 | 72.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.03 | -0.27 | -0.31 | -0.19 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.28 | -0.33 | -0.20 |
| Dividend Paid and CapEx Coverage Ratio | -1010926.00 | -1270611.00 | -43.68 | -17.15 | -23.16 |
| Capital Expenditure Coverage Ratio | -1010926.00 | -1270611.00 | -43.68 | -17.15 | -23.16 |
| Operating Cash Flow Coverage Ratio | -1.58 | -0.45 | -1.38 | -1.89 | -110.14 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.48 | -7.68 | -18.38 | -21.77 |
| Free Cash Flow Yield | -58.29% | -122.92% | -78.60% | -34.22% | -6.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.61 | -0.50 | -0.87 | -2.74 | -13.21 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.39 | 9.99 | 56.84 | 341.88 |
| Price-to-Book (P/B) Ratio | -3.21 | -0.45 | -2.86 | 5.75 | 5.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.72 | -0.81 | -1.27 | -2.92 | -15.06 |
| Price-to-Operating Cash Flow Ratio | -1.72 | -0.81 | -1.30 | -3.09 | -15.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | -0.05 | -0.05 | 0.64 |
| Enterprise Value Multiple | -2.14 | -1.73 | -1.61 | -2.46 | -11.80 |
| Enterprise Value | 7.65M | 1.21M | 16.63M | 27.07M | 66.26M |
| EV to EBITDA | -2.14 | -1.73 | -1.61 | -2.46 | -11.80 |
| EV to Sales | 0.00 | 0.45 | 15.36 | 57.18 | 284.56 |
| EV to Free Cash Flow | -1.89 | -0.95 | -1.96 | -2.94 | -12.53 |
| EV to Operating Cash Flow | -1.89 | -0.95 | -2.00 | -3.11 | -13.07 |
| Tangible Book Value Per Share | -0.01 | -0.05 | -0.12 | 0.17 | 0.51 |
| Shareholders’ Equity Per Share | -0.01 | -0.05 | -0.12 | 0.17 | 0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.17 | 0.22 | 0.26 | 0.43 |
| Revenue Per Share | 0.00 | 0.06 | 0.04 | 0.02 | 0.01 |
| Net Income Per Share | -0.02 | -0.05 | -0.41 | -0.35 | -0.23 |
| Tax Burden | 0.99 | 0.83 | 0.78 | 1.00 | 1.00 |
| Interest Burden | 1.21 | 3.35 | 1.39 | 0.81 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.15 | 4.85 | 7.64 | 11.61 |
| SG&A to Revenue | 0.00 | 0.98 | 3.31 | 11.65 | 16.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.43 | 1.38 | 2.14 |
| Income Quality | 0.94 | 0.61 | 0.67 | 0.89 | 0.84 |
Currency in AUD

